Johnson & Johnson shares fall after company beats on earnings and revenue, but lowers pharmaceutical sales guidance
J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year.
Fox News and Dominion defamation trial delayed ahead of opening arguments
Dominion accused Fox of “intentionally and falsely” blaming it for former Donald Trump’s loss to Joe Biden.
10-year Treasury yield inches lower as Wall Street weighs economic outlook
The yield on the 10-year Treasury note inched lower as investors assessed the outlook for the U.S. economy and digested the latest round of corporate earnings.
Oklahoma county leaders caught on audio talking about killing reporters, complaining they can no longer lynch Black people
“I am both appalled and disheartened to hear of the horrid comments made by officials in McCurtain County,” Gov. Kevin Stitt said.
Rep. George Santos, who admitted lying about his resume, announces 2024 reelection bid
Santos’ brief tenure in Congress has been marked by a cavalcade of scandals, including admitting he lied about key details of his resume.
How to set up Apple’s new savings account on an iPhone
The Apple Savings account can take up to $250,000 in deposits, which are insured by the FDIC.
Moderna shares fall despite promising data from cancer vaccine trial
Moderna’s mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Wells Fargo says this little-known biotech company could rally more than 80%
Analyst Derek Archila said shares of Viridian Therapeutics have more than 80% upside, citing a promising treatment for thyroid eye disease currently in trials.
Homebuilder sentiment rises in April, as builders grab near-record share of the market
Homebuilder sentiment rose in April, as builders gained an edge from a lack of supply on the resale market.
